Tüm alıştırma soruları

8270 soru

Soru 2221Soru →

A cohort of healthy female patients is observed longitudinally in a primary care setting to track the normative progression of adolescent physical maturation. Arrange the following hallmark physiological events in the most typical chronological sequence of their onset, from earliest to latest.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The normal chronological sequence is thelarche, followed by pubarche, peak height velocity, and finally menarche.
Normal female pubertal development follows a predictable physiological timeline. It classically begins with thelarche (breast budding, Tanner stage II) at approximately 9 to 10 years of age, driven by ovarian estrogens. This is followed within a few months by pubarche (pubic hair development), mediated largely by adrenal androgens. The adolescent growth spurt accelerates subsequently, with peak height velocity achieved typically between 11.5 and 12.5 years of age (Tanner stage III-IV). Finally, menarche occurs as a late pubertal event (Tanner stage IV), typically at age 12.5 to 13 years, which is about 2 to 2.5 years after the initial onset of thelarche.

Adım Adım Çözüm

1
Identify the initial sign of female puberty.
Thelarche (breast budding) marks the onset of puberty.
Ovarian estrogen production initiates breast tissue development (Tanner stage II) before other major somatic changes occur, typically around age 9 to 10.
2
Determine the subsequent manifestation.
Pubarche (pubic hair development) appears shortly after thelarche.
Adrenarche and increasing gonadal androgens stimulate pubic and axillary hair growth, usually presenting at age 10 to 10.5.
3
Sequence the adolescent growth spurt.
Peak height velocity is achieved.
The maximum rate of linear growth occurs during Tanner stages III to IV (typically around age 11.5 to 12), as the synergistic effects of growth hormone and estradiol peak.
4
Identify the final major hallmark.
Menarche occurs.
The first menstrual period is a late-stage pubertal event, signaling maturation of the hypothalamic-pituitary-ovarian axis (around age 12.5 to 13), and is followed shortly by epiphyseal closure.

Anahtar Kavram

Chronological sequence of normal female pubertal development
Soru 2222Soru →

A pediatric clinic is reviewing its protocols for vaccine safety and administration. Match each pediatric patient's clinical history to the corresponding vaccine contraindication or appropriate management step.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 2-month-old infant with a past medical history of intussusception
A 4-month-old infant who developed unexplained encephalopathy 3 days after receiving their 2-month immunizations
A 12-month-old child recently diagnosed with severe combined immunodeficiency (SCID)
A 6-month-old infant who experiences isolated hives after eating eggs

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The infant with intussusception matches with the rotavirus vaccine contraindication; the infant with encephalopathy matches with the pertussis vaccine contraindication; the child with SCID matches with the live-attenuated vaccine contraindication; and the infant with an egg allergy matches with no contraindication.
Each clinical presentation aligns with a specific immunization rule. Intussusception history strictly contraindicates rotavirus vaccination. Unexplained encephalopathy within 7 days of a DTaP dose strictly contraindicates further pertussis vaccination. Severe cellular immunodeficiency (SCID) strictly contraindicates all live-attenuated vaccines (like MMR and Varicella). Conversely, egg allergy is a false contraindication; the influenza vaccine can and should be administered safely.

Adım Adım Çözüm

1
Evaluate the patient with a history of intussusception
Identify that rotavirus vaccine is contraindicated
The rotavirus vaccine specifically increases the risk of intussusception, making prior episodes an absolute contraindication.
2
Evaluate the patient who developed encephalopathy after prior immunizations
Identify that pertussis-containing vaccines (DTaP) are contraindicated
Encephalopathy within 7 days of administration is an absolute contraindication specifically for the pertussis component of the DTaP vaccine.
3
Evaluate the patient with severe combined immunodeficiency (SCID)
Identify that live-attenuated vaccines are contraindicated
Patients with severe cellular immunodeficiency cannot mount a proper immune response and are at high risk of developing severe systemic infections from live vaccine strains.
4
Evaluate the patient with an egg allergy
Identify that there is no contraindication for routine vaccines
Current guidelines state that egg allergy of any severity is not a contraindication to the influenza vaccine (or any other routine childhood vaccine), and it can be safely given in routine settings.

Anahtar Kavram

True versus false absolute contraindications for routine childhood immunizations.
Soru 2223Soru →

During a pre-scheduled visit for health maintenance, a physician evaluates a 1-year-old male infant. Medical history is notable for severe atopic dermatitis, which recently necessitated a prolonged course of systemic corticosteroids. Specifically, he has been taking oral prednisone (2 mg/kg daily) for the past 28 days. His skin flare has now largely resolved, and the physician plans a gradual taper of the medication. The infant is clinically stable, afebrile, and behaving normally. According to his medical records, he received all indicated immunizations during his first 6 months of life. As the physician prepares orders for today's routine immunizations, which of the following preparations is strictly contraindicated at this time?

Cevabı ve açıklamayı göster

Cevap: Measles-mumps-rubella vaccine

Cevap

The measles-mumps-rubella (MMR) vaccine is strictly contraindicated because it is a live-attenuated vaccine and the patient is currently severely immunocompromised from high-dose corticosteroid therapy.
The correct answer is the measles-mumps-rubella (MMR) vaccine. Patients receiving high-dose systemic corticosteroids, defined as greater than or equal to 2 mg/kg/day (or 20 mg/day) of prednisone for 14 days or longer, are considered severely immunocompromised. In such patients, all live-attenuated vaccines, including the MMR and varicella vaccines, are strictly contraindicated due to the severe risk of uncontrolled vaccine-strain viral replication and disseminated infection. High-dose systemic steroids must be discontinued for at least 1 month before live vaccines can be safely administered.

Adım Adım Çözüm

1
Identify the patient's current medication status and dosage.
The patient has been taking 2 mg/kg/day of oral prednisone for 28 days.
Corticosteroid dosage and duration determine the degree of pharmacologic immunosuppression.
2
Determine if the medication regimen meets the criteria for severe immunosuppression.
Yes. A dose of 2 mg/kg/day (or 20 mg/day) of prednisone for 14 or more consecutive days constitutes severe immunosuppression.
This specific threshold is used by the CDC to determine when live vaccines can be safely administered to pediatric patients.
3
Classify the routine 12-month vaccine options into live-attenuated versus inactivated categories.
The MMR vaccine is live-attenuated, while Hib, Hepatitis A, Hepatitis B, and Pneumococcal conjugate vaccines are inactivated or subunit formulations.
Live-attenuated vaccines are contraindicated during severe immunosuppression due to the risk of uncontrolled vaccine-strain viral replication, whereas inactivated vaccines are safe to administer.

Anahtar Kavram

Patients receiving high-dose systemic corticosteroids (≥2 mg/kg/day or ≥20 mg/day of prednisone for ≥14 days) are considered severely immunocompromised and should not receive live-attenuated vaccines such as MMR and varicella until therapy is discontinued for at least 1 month.
Soru 2224Soru →

A 55-year-old man comes to the urgent care clinic with sudden, severe pain and swelling in his right big toe that awoke him from sleep. He has a history of hypertension and recently recovered from a mild respiratory illness. Vital signs are within normal limits. Physical examination reveals a markedly erythematous, warm, and exquisitely tender right first metatarsophalangeal joint. Synovial fluid analysis shows a leukocyte count of 18,000/µL. Polarized light microscopy of the fluid reveals needle-shaped, negatively birefringent crystals, and the Gram stain is negative. Which of the following is the most appropriate initial management for this patient's current condition?

Cevabı ve açıklamayı göster

Cevap: Oral colchicine

Cevap

Oral colchicine
The patient's presentation of podagra (inflammation of the first metatarsophalangeal joint) along with synovial fluid showing needle-shaped, negatively birefringent crystals confirms the diagnosis of an acute gout flare. First-line medical therapy for acute gout includes NSAIDs, colchicine, or glucocorticoids. Oral colchicine is highly effective when started early in the course of an attack.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and synovial fluid results.
The patient has acute monoarticular arthritis of the first metatarsophalangeal joint (podagra) with negatively birefringent, needle-shaped crystals.
Identifying the crystals is the definitive step to differentiate between various causes of acute monoarthritis.
2
Diagnose the underlying condition.
The diagnosis is an acute gout flare, caused by monosodium urate crystal deposition.
Negatively birefringent needle-shaped crystals are pathognomonic for gout, whereas pseudogout would show weakly positively birefringent rhomboid crystals.
3
Determine the most appropriate initial therapy.
First-line therapies for acute gout include NSAIDs, colchicine, or systemic glucocorticoids.
These agents rapidly reduce acute inflammation. Urate-lowering therapies are generally not initiated during an acute flare without concurrent anti-inflammatory prophylaxis.

Anahtar Kavram

Diagnosis and acute management of gout
Soru 2225Soru →

A 32-year-old woman comes to the clinic due to progressive fatigue and decreased exercise tolerance over the past 4 months. She has no significant past medical history and takes no medications. The patient reports having heavy menstrual periods, often soaking a pad every 2 hours during the first 3 days of her cycle. Vital signs are within normal limits. Physical examination shows mild conjunctival pallor but no jaundice or organomegaly. Laboratory studies show:

Hemoglobin: 9.8 g/dL
Mean corpuscular volume (MCV): 74 fL
White blood cell count: 6,500/mm³
Platelet count: 410,000/mm³

Which of the following is the most appropriate initial diagnostic test for this patient?

Cevabı ve açıklamayı göster

Cevap: Serum iron studies

Cevap

Serum iron studies
The correct answer is serum iron studies. The patient presents with fatigue, conjunctival pallor, and heavy menstrual bleeding, along with laboratory evidence of a microcytic anemia (MCV < 80 fL) and reactive thrombocytosis. This clinical picture is highly suggestive of iron deficiency anemia secondary to chronic blood loss. The most appropriate initial step in the diagnostic workup of microcytic anemia is to check serum iron studies (including ferritin, iron, and total iron-binding capacity) to confirm iron deficiency before initiating therapy.

Adım Adım Çözüm

1
Classify the patient's anemia based on the laboratory values.
The patient has a hemoglobin of 9.8 g/dL and an MCV of 74 fL, indicating a microcytic anemia.
Categorizing anemia by MCV narrows the differential diagnosis to microcytic, normocytic, or macrocytic causes.
2
Correlate the laboratory findings with the clinical history.
The history of heavy menstrual bleeding strongly points to chronic blood loss as the underlying cause of the microcytic anemia.
Chronic blood loss is the leading cause of iron deficiency anemia in premenopausal women.
3
Identify the standard diagnostic workup for the suspected condition.
The most appropriate next step is to obtain serum iron studies (including ferritin, serum iron, and total iron-binding capacity).
Noninvasive iron studies are required to formally diagnose iron deficiency before initiating supplementation.

Anahtar Kavram

Evaluation of microcytic anemia and diagnosis of iron deficiency
Soru 2226Soru →

An emergency medical services team brings a 68-year-old woman to the resuscitation bay in January due to progressive lethargy and generalized swelling over the past 48 hours. Two weeks ago, she experienced a mild upper respiratory tract infection. Her past medical history is notable for hypertension, hyperlipidemia, and a severe postpartum hemorrhage requiring multiple blood transfusions 38 years ago. Current medications include amlodipine and atorvastatin. Vital signs show a temperature of 34.2°C (93.6°F), blood pressure of 88/56 mm Hg, heart rate of 48/min, and respiratory rate of 8/min. Pulse oximetry is 90% on room air. Physical examination reveals a somnolent patient who only awakens to painful stimuli. Her face appears puffy with marked periorbital edema, and deep tendon reflexes exhibit significantly delayed relaxation. Lung fields are clear to auscultation.

Initial laboratory testing reveals the following:
Sodium: 124 mEq/L
Potassium: 4.1 mEq/L
Chloride: 92 mEq/L
Bicarbonate: 26 mEq/L

Arterial blood gas (room air):
pH: 7.24
PaCO2: 68 mm Hg
PaO2: 62 mm Hg

Thyroid-stimulating hormone (TSH): 1.5 mU/L (Normal: 0.5–5.0 mU/L)
Free T4: 0.3 ng/dL (Normal: 0.9–1.7 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Administer intravenous hydrocortisone prior to intravenous levothyroxine

Cevap

Administer intravenous hydrocortisone prior to intravenous levothyroxine
The correct sequence of therapy requires recognizing that this patient has myxedema coma caused by panhypopituitarism, likely Sheehan syndrome, given her history of severe postpartum hemorrhage and a thyroid panel showing central hypothyroidism (low Free T4, normal TSH). Because central adrenal insufficiency is concurrently present, administering levothyroxine alone will accelerate the metabolic clearance of cortisol and provoke a fatal acute adrenal crisis. Intravenous hydrocortisone must be given first to provide stress-dose steroid coverage.

Adım Adım Çözüm

1
Identify the clinical syndrome
The patient is presenting with myxedema coma, evidenced by profound hypothermia, bradycardia, altered mental status, delayed deep tendon reflexes, and non-pitting edema.
Recognizing the life-threatening extreme of hypothyroidism is required to initiate emergency endocrine resuscitation.
2
Analyze the acid-base and electrolyte status
The patient has severe hyponatremia and acute uncompensated respiratory acidosis (low pH, high PaCO2) driven by hypoventilation.
This confirms the severity of the myxedema coma and rules out primary metabolic causes for the acidemia.
3
Interpret the thyroid panel
The patient has a low Free T4 (0.3 ng/dL) with an inappropriately normal TSH (1.5 mU/L).
This laboratory pattern indicates central (secondary) hypothyroidism rather than primary hypothyroidism (where TSH would be markedly elevated).
4
Synthesize the endocrine history
The history of severe postpartum hemorrhage 38 years ago, combined with central hypothyroidism, points to Sheehan syndrome (postpartum pituitary necrosis) leading to panhypopituitarism.
Panhypopituitarism implies concurrent deficiencies in other pituitary hormones, most critically ACTH, resulting in central adrenal insufficiency.
5
Determine the pharmacological sequence
Intravenous hydrocortisone must be administered before or simultaneously with intravenous levothyroxine.
Administering thyroid hormone increases basal metabolic rate and hepatic clearance of cortisol. In a patient with untreated adrenal insufficiency, this will precipitate a fatal acute adrenal crisis.

Anahtar Kavram

In patients with suspected panhypopituitarism (e.g., Sheehan syndrome) presenting with myxedema coma, glucocorticoids must be administered before thyroid hormone replacement to avoid precipitating an acute adrenal crisis.
Soru 2227Soru →

Match each classic physical examination finding with the most likely rheumatologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Hard, bony outgrowths at the distal interphalangeal (DIP) joints
Violaceous, slightly scaly papules and plaques over the metacarpophalangeal (MCP) joints
Diffuse, uniform swelling of a single digit with accompanying nail pitting
Symmetric MCP joint swelling with ulnar deviation and subluxation

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Bony DIP outgrowths correspond to osteoarthritis. Violaceous knuckle plaques correspond to dermatomyositis. Diffuse digit swelling with nail pitting corresponds to psoriatic arthritis. Symmetric MCP swelling with ulnar deviation corresponds to rheumatoid arthritis.
Each rheumatologic condition has a classic physical examination signature. Osteoarthritis causes osteophyte formation (Heberden nodes at DIP, Bouchard nodes at PIP). Dermatomyositis presents with pathognomonic skin findings like Gottron papules on the knuckles. Psoriatic arthritis often involves dactylitis (sausage digits) and nail changes due to enthesitis. Rheumatoid arthritis causes erosive, symmetric synovitis leading to ulnar deviation and subluxation at the MCP joints.

Adım Adım Çözüm

1
Analyze the specific joint involvement and associated dermatologic findings for each presentation.
Identified distinct patterns pathognomonic for four major rheumatologic diseases.
Pattern recognition of physical exam findings is the primary step in diagnosing and differentiating rheumatologic conditions.

Anahtar Kavram

Physical examination hallmarks in rheumatologic diseases
Soru 2228Soru →

A medical student is reviewing common adverse effects of antihypertensive medications frequently prescribed in the primary care setting. Match each patient's clinical presentation to the antihypertensive medication most likely responsible for their symptoms.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old woman develops a persistent, dry, hacking cough a few weeks after starting a new medication for hypertension.
A 62-year-old man presents with bilateral, pitting ankle edema that worsens by the end of the day.
A 48-year-old man presents with acute, severe pain, swelling, and erythema in his right first metatarsophalangeal joint.
A 50-year-old man complains of new-onset fatigue, exercise intolerance, and cold extremities.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align the persistent dry cough with Lisinopril, the pitting ankle edema with Amlodipine, the acute gout flare with Hydrochlorothiazide, and the fatigue with cold extremities with Metoprolol.
Each clinical presentation represents a classic, high-yield adverse effect of a primary antihypertensive drug class. Lisinopril (ACE inhibitor) causes a bradykinin-mediated cough. Amlodipine (calcium channel blocker) causes peripheral edema via precapillary vasodilation. Hydrochlorothiazide (thiazide diuretic) decreases renal uric acid excretion, precipitating gout. Metoprolol (beta-blocker) reduces cardiac output, leading to fatigue and cold extremities.

Adım Adım Çözüm

1
Analyze the first presentation (dry cough).
Identified as a bradykinin-mediated adverse effect.
Points to an ACE inhibitor (Lisinopril).
2
Analyze the second presentation (pitting ankle edema).
Identified as a precapillary vasodilation effect.
Points to a dihydropyridine calcium channel blocker (Amlodipine).
3
Analyze the third presentation (acute gout flare).
Identified as a consequence of reduced renal uric acid clearance.
Points to a thiazide diuretic (Hydrochlorothiazide).
4
Analyze the fourth presentation (fatigue and cold extremities).
Identified as a result of reduced cardiac output and peripheral vasoconstriction.
Points to a beta-blocker (Metoprolol).

Anahtar Kavram

Adverse effects of first-line antihypertensive medications.
Soru 2229Soru →

A 62-year-old man is evaluated in the hematology-oncology unit for persistent daily fevers. He was admitted 14 days ago to undergo induction chemotherapy for acute myeloid leukemia. Four days ago, he developed a fever of 38.9°C (102.0°F) when his absolute neutrophil count (ANC) was 200/mm³. After blood cultures were obtained, empiric intravenous cefepime was initiated. Today, his temperature is 38.8°C (101.8°F), blood pressure is 118/76 mmHg, pulse is 98/min, and respiratory rate is 18/min. His current ANC is 100/mm³. The initial blood cultures have shown no growth after 96 hours. The patient now reports the onset of mild, right-sided pleuritic chest pain. Physical examination reveals normal heart sounds and clear lung fields bilaterally. His tunneled central venous catheter site appears clean with no surrounding erythema or induration. A non-contrast chest CT demonstrates a 2.5-cm dense nodule in the right upper lobe surrounded by a distinct rim of ground-glass opacity. Serum galactomannan and beta-D-glucan assays are drawn and pending. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate intravenous voriconazole

Cevap

The most appropriate next step is to initiate intravenous voriconazole.
This patient's clinical picture is classic for invasive pulmonary aspergillosis (IPA). He has prolonged neutropenic fever unresponsive to broad-spectrum antibacterials, combined with a new onset of pleuritic chest pain and a defining 'halo sign' on his chest CT. The halo sign is caused by a central pulmonary nodule (representing tissue infarction) surrounded by a ring of ground-glass opacity (representing alveolar hemorrhage), which occurs due to the angioinvasive nature of Aspergillus. In profoundly immunocompromised patients, delayed treatment of invasive mold infections is associated with exceedingly high mortality. Therefore, the most appropriate next step is to initiate empiric antifungal therapy with a mold-active triazole, such as voriconazole or isavuconazole, while awaiting definitive diagnostic results like the serum galactomannan assay.

Adım Adım Çözüm

1
Analyze the clinical timeline and immune status.
The patient has profound neutropenia (ANC < 500/mm³) and persistent fever for 4 days despite broad-spectrum antipseudomonal beta-lactam therapy (cefepime).
Persistent fever in a neutropenic patient beyond 4-7 days of appropriate antibacterial therapy raises the clinical suspicion for invasive fungal infections.
2
Interpret the new clinical and radiographic findings.
Pleuritic chest pain combined with a CT showing a pulmonary nodule surrounded by ground-glass opacity (the 'halo sign').
The 'halo sign' represents a central area of pulmonary infarction surrounded by alveolar hemorrhage, which is highly characteristic of angioinvasive fungi, primarily Aspergillus species.
3
Determine the standard of care intervention.
Selection of a mold-active triazole (voriconazole or isavuconazole) immediately, rather than waiting for serum galactomannan results.
Invasive pulmonary aspergillosis has a very high mortality rate in neutropenic patients; delaying therapy for definitive diagnostic test results is contraindicated.

Anahtar Kavram

Invasive Pulmonary Aspergillosis Management in Neutropenia
Tahmini Süre:1m 30s
Soru 2230Soru →

A 54-year-old woman is brought to the emergency department by her daughter after experiencing a witnessed generalized tonic-clonic seizure. The patient has a history of severe systemic lupus erythematosus and is currently managed with chronic cyclophosphamide and high-dose prednisone. Her temperature is 39.3°C (102.7°F), blood pressure is 142/88 mm Hg, and heart rate is 114/min. She is postictal and difficult to arouse. Neurologic examination is limited by her somnolence but reveals profound nuchal rigidity. Arrange the following diagnostic and therapeutic steps in the most appropriate sequential order for the immediate management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first obtain peripheral blood cultures, immediately administer intravenous dexamethasone and empiric antimicrobial therapy, then perform a non-contrast CT scan of the head, followed by a lumbar puncture, and finally de-escalate the antimicrobial therapy based on microbiological data.
The correct management algorithm for suspected bacterial meningitis requires immediate assessment for indications to perform a CT scan before a lumbar puncture. These indications include immunocompromised state, history of central nervous system disease, new-onset seizure, papilledema, altered consciousness, and focal neurologic deficits. Because this patient is severely immunocompromised (chronic cyclophosphamide and prednisone) and presents with a new-onset seizure, a CT scan is mandatory. In such cases, it is critical not to delay therapy; peripheral blood cultures must be drawn immediately, followed by the administration of empiric broad-spectrum antibiotics and dexamethasone. Only after therapy is initiated should the patient be sent for a CT scan. Once the CT scan rules out significant mass effect, a lumbar puncture is performed safely. Finally, the broad-spectrum regimen is tailored based on the final microbiological culture and sensitivity results.

Adım Adım Çözüm

1
Identify the indications for neuroimaging prior to lumbar puncture.
The patient's immunosuppressive regimen and new-onset seizure mandate a head CT to rule out mass effect.
Performing an unguided lumbar puncture in a patient with a potential mass lesion can precipitate fatal cerebral herniation.
2
Obtain blood cultures.
Microbiological samples are secured before the administration of antibiotics.
Antibiotics can rapidly sterilize the blood, severely reducing the diagnostic yield of subsequent cultures.
3
Administer empiric antibiotics and dexamethasone.
Life-saving antimicrobial therapy is initiated immediately.
Mortality increases significantly if antibiotics are delayed while waiting for a CT scan to be performed and read.
4
Perform the non-contrast head CT, followed by the lumbar puncture.
The safety of the lumbar puncture is confirmed, and cerebrospinal fluid is obtained for Gram stain and culture.
Provides definitive microbiological data to guide long-term directed therapy once it is safe to do so.

Anahtar Kavram

In patients with suspected bacterial meningitis who have indications for a CT scan prior to lumbar puncture (e.g., immunosuppression, new-onset seizure, focal neurologic deficit), blood cultures must be drawn and empiric antibiotics administered BEFORE the CT scan to prevent treatment delays.
Tahmini Süre:1m 30s
Soru 2231Soru →

A 72-year-old retired mechanic presents to the emergency department with a 3-day history of progressively worsening shortness of breath. He reports needing to sleep propped up on three pillows and has developed a new nocturnal cough producing frothy white sputum. His medical history includes severe chronic obstructive pulmonary disease (COPD), a myocardial infarction three years ago, and chronic fatigue. His only home medications are a tiotropium inhaler and aspirin.

Vital signs show a temperature of 37.0°C (98.6°F), blood pressure of 160/90 mm Hg, heart rate of 110/min, and respiratory rate of 26/min. Pulse oximetry is 88% on room air.

Physical examination reveals an anxious man using accessory muscles of respiration. Jugular venous pressure is measured at 10 cm H2OH_2O. Chest auscultation reveals diffuse bilateral expiratory wheezes and fine bibasilar crackles. An S3 gallop is heard at the cardiac apex. The lower extremities show bilateral 2+ pitting edema.

Initial laboratory studies show:
Leukocyte count: 8,500/mm3mm^3
Brain natriuretic peptide (BNP): 920 pg/mL (normal < 100)
Thyroid-stimulating hormone (TSH): 1.5 μU/mL\mu U/mL (normal: 0.5-5.0)
Free T4: 0.6 ng/dL (normal: 0.9-1.7)

Arterial blood gas on room air:
pH: 7.28
PaCO2PaCO_2: 58 mm Hg
PaO2PaO_2: 54 mm Hg
HCO3−HCO_3^-: 26 mEq/L

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intravenous administration of bumetanide

Cevap

Intravenous administration of bumetanide
The correct intervention is the intravenous administration of a loop diuretic, such as bumetanide. The patient's clinical presentation is classic for acute decompensated heart failure (ADHF) with cardiogenic pulmonary edema. While he has a history of COPD, the combination of orthopnea, elevated jugular venous pressure, an S3 gallop, bibasilar crackles, and an elevated BNP level strongly confirms ADHF. The diffuse wheezing is a manifestation of peribronchial edema, often termed 'cardiac asthma.' Initial management of ADHF requires supplemental oxygen and rapid preload reduction using intravenous loop diuretics.

Adım Adım Çözüm

1
Evaluate the primary cause of acute respiratory distress based on physical exam and laboratory findings.
Findings of orthopnea, elevated jugular venous pressure, an S3 gallop, bibasilar crackles, and an elevated brain natriuretic peptide (BNP) indicate acute decompensated heart failure (ADHF) with pulmonary edema.
Differentiating between ADHF and a COPD exacerbation is a critical first step, as both can present with dyspnea, hypoxia, and wheezing ('cardiac asthma').
2
Analyze the arterial blood gas results.
An acute, uncompensated respiratory acidosis is present, which is consistent with poor gas exchange secondary to severe pulmonary edema.
Understanding the primary acid-base disturbance ensures the clinician avoids treating secondary physiological compensations inappropriately.
3
Select the most appropriate initial pharmacological intervention.
Intravenous loop diuretics (such as bumetanide or torsemide) are indicated alongside supplemental oxygen.
Loop diuretics rapidly reduce intravascular volume and right-sided preload, effectively relieving pulmonary congestion and improving oxygenation.

Anahtar Kavram

Differentiating acute decompensated heart failure (cardiac asthma) from a COPD exacerbation, and initiating appropriate acute management with intravenous loop diuretics.
Tahmini Süre:1m 30s
Soru 2232Soru →

Match each classic clinical presentation to the most likely hematologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 65-year-old man with progressive lower back pain, hypercalcemia, and acute kidney injury.
A 25-year-old woman with painless cervical lymphadenopathy and a widening mediastinum on chest x-ray.
A 60-year-old man with fatigue, early satiety due to massive splenomegaly, and a BCR-ABL1 mutation.
A 70-year-old asymptomatic man found to have marked, isolated absolute lymphocytosis on routine blood work.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patient with back pain and hypercalcemia matches Multiple myeloma. The young woman with a mediastinal mass matches Hodgkin lymphoma. The patient with massive splenomegaly and BCR-ABL1 matches Chronic myeloid leukemia. The asymptomatic elderly man with lymphocytosis matches Chronic lymphocytic leukemia.
Each clinical vignette provides pathognomonic or highly characteristic features for its respective malignancy. Multiple myeloma features CRAB criteria. Hodgkin lymphoma classically affects young adults with cervical and mediastinal adenopathy. Chronic myeloid leukemia is defined by the BCR-ABL1 translocation and often presents with splenomegaly. Chronic lymphocytic leukemia typically presents as an incidental extreme lymphocytosis in older adults.

Adım Adım Çözüm

1
Analyze the first presentation (back pain, hypercalcemia, kidney injury).
Identifies the diagnosis as Multiple myeloma.
These symptoms fulfill the CRAB criteria (Calcium, Renal, Anemia, Bone) characteristic of this plasma cell dyscrasia.
2
Analyze the second presentation (young female, painless lymphadenopathy, mediastinal mass).
Identifies the diagnosis as Hodgkin lymphoma.
This matches the classic bimodal age distribution and typical nodal involvement of this lymphoma.
3
Analyze the third presentation (splenomegaly, BCR-ABL1 mutation).
Identifies the diagnosis as Chronic myeloid leukemia.
Early satiety from splenomegaly and the BCR-ABL1 mutation are the hallmark diagnostic features.
4
Analyze the fourth presentation (elderly, asymptomatic lymphocytosis).
Identifies the diagnosis as Chronic lymphocytic leukemia.
This is the most common presentation of CLL, often discovered incidentally on routine laboratory testing.

Anahtar Kavram

Classic clinical presentations of major hematologic malignancies
Soru 2233Soru →

A 48-year-old woman with a history of limited cutaneous systemic sclerosis presents to the clinic with worsening episodes of painful blanching and cyanosis in her fingers upon cold exposure. She states that these episodes are becoming more frequent and severe despite wearing insulated gloves and strictly avoiding cold temperatures. Her physical examination is notable for sclerodactyly and multiple telangiectasias on her face and hands. No digital ulcers are currently present, but capillary refill is delayed during an episode in the clinic. Arrange the following therapeutic interventions in the correct order of escalation for the management of this patient's Raynaud phenomenon, starting from the most appropriate initial pharmacologic treatment to the therapy of last resort for critical digital ischemia.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct escalation sequence is: 1) oral calcium channel blockers, 2) oral phosphodiesterase-5 inhibitors, 3) intravenous prostanoids, 4) surgical digital sympathectomy.
The standard of care for severe secondary Raynaud phenomenon follows a stepwise escalation: lifestyle modifications are followed by oral calcium channel blockers as first-line pharmacotherapy. If symptoms persist, a phosphodiesterase-5 inhibitor is added. For severe refractory disease with critical ischemia or digital ulcers, intravenous prostanoids are administered. Surgical digital sympathectomy is strictly a treatment of last resort for imminent tissue loss.

Adım Adım Çözüm

1
Identify the underlying condition and the failure of initial conservative management.
The patient has secondary Raynaud phenomenon due to systemic sclerosis and has already failed lifestyle modifications (cold avoidance).
Confirming the failure of conservative measures justifies the initiation of pharmacologic therapy.
2
Determine the first-line pharmacologic agent for secondary Raynaud phenomenon.
Oral dihydropyridine calcium channel blockers (e.g., nifedipine, amlodipine) are selected as the initial medical intervention.
These agents promote vasodilation and are the most effective initial oral medications for reducing the frequency of attacks.
3
Identify the next step if first-line monotherapy is insufficient.
An oral phosphodiesterase-5 inhibitor (e.g., sildenafil) is added as second-line therapy.
PDE-5 inhibitors provide additional vasodilation through the nitric oxide pathway for patients with refractory symptoms.
4
Determine the intervention for severe, treatment-resistant disease or critical ischemia.
Intravenous prostanoids (e.g., epoprostenol) are utilized for severe ischemia or active digital ulceration.
IV prostanoids are potent vasodilators but require intravenous access and close monitoring, limiting their use to severe cases.
5
Identify the definitive treatment of last resort.
Surgical digital sympathectomy is placed at the end of the algorithm.
This is an invasive surgical procedure considered only for limb-threatening ischemia when maximal medical therapy has completely failed.

Anahtar Kavram

Stepwise escalation of therapy in secondary Raynaud phenomenon
Tahmini Süre:1m 30s
Soru 2234Soru →

A 65-year-old man presents to the clinic with a 3-week history of progressively worsening shortness of breath and swelling in his legs. He reports waking up in the middle of the night gasping for air and now requires three pillows to sleep comfortably. His medical history is significant for severe, erosive rheumatoid arthritis, chronic obstructive pulmonary disease, and hypertension. His medications include methotrexate, lisinopril, tiotropium, and acetaminophen. Three months ago, his rheumatologist added etanercept due to inadequately controlled joint symptoms. He has a 40-pack-year smoking history but quit 5 years ago. Vital signs show a temperature of 37.0°C (98.6°F), blood pressure of 145/85 mmHg, pulse of 96/min, and respiratory rate of 22/min. Pulse oximetry shows 94% on room air. Physical examination reveals distended jugular veins, bibasilar lung crackles, and 3+ bilateral pitting edema up to the knees. Cardiac auscultation reveals a regular rhythm with an S3 gallop. Joint examination shows chronic deformities but no acute inflammation. Which of the following is the most likely cause of this patient's current presentation?

Cevabı ve açıklamayı göster

Cevap: Toxic effect of a biologic agent on ventricular function

Cevap

Toxic effect of a biologic agent on ventricular function
The patient's presentation of progressive dyspnea, orthopnea, paroxysmal nocturnal dyspnea, jugular venous distension, bibasilar crackles, an S3 gallop, and lower extremity edema is the classic clinical picture of acute decompensated heart failure (ADHF). Tumor necrosis factor (TNF)-alpha inhibitors, such as etanercept, infliximab, and adalimumab, are biologic disease-modifying antirheumatic drugs (DMARDs) used for severe rheumatoid arthritis. A well-documented and highly tested adverse effect of TNF-alpha inhibitors is the development of new-onset heart failure or the exacerbation of underlying heart failure. Therefore, these agents should be used with extreme caution or completely avoided in patients with moderate to severe heart failure. The addition of etanercept three months ago is the most likely culprit for his sudden ventricular dysfunction and subsequent volume overload.

Adım Adım Çözüm

1
Analyze the clinical presentation and physical examination findings.
The patient presents with orthopnea, paroxysmal nocturnal dyspnea, jugular venous distension, bibasilar crackles, an S3 gallop, and severe pitting edema.
To establish the primary physiologic syndrome, which is acute decompensated heart failure characterized by profound volume overload.
2
Review the patient's medical history and recent medication changes.
The patient has a history of severe rheumatoid arthritis and recently started etanercept three months ago.
To identify potential triggers, etiologies, or iatrogenic causes for the new-onset heart failure.
3
Connect the medication profile to the clinical syndrome.
Etanercept is a TNF-alpha inhibitor, a class of drugs known to cause or worsen heart failure.
Recognizing this adverse effect identifies the most likely cause of the patient's acute decompensation, as TNF-alpha inhibitors are strictly contraindicated in moderate-to-severe heart failure.

Anahtar Kavram

Tumor necrosis factor (TNF)-alpha inhibitors (e.g., etanercept, infliximab, adalimumab) can cause new-onset heart failure or exacerbate underlying heart failure, and their use is contraindicated in patients with moderate to severe ventricular dysfunction.
Tahmini Süre:1m 30s
Soru 2235Soru →

A 65-year-old woman is brought to the emergency department due to progressive confusion, generalized weakness, and recurrent vomiting over the past 4 days. Her medical history is significant for breast cancer treated with a lumpectomy, radiation, and chemotherapy 6 years ago. Vital signs show a temperature of 37.1°C (98.8°F), blood pressure of 100/60 mm Hg, heart rate of 112/min, and respiratory rate of 14/min. Physical examination is notable for dry mucous membranes, delayed capillary refill, and lethargy.

Laboratory evaluation reveals the following:

Laboratory TestResultReference Range
Serum calcium15.6 mg/dL8.4-10.2 mg/dL
Serum albumin3.8 g/dL3.5-5.0 g/dL
Serum creatinine2.1 mg/dL0.6-1.1 mg/dL

An electrocardiogram demonstrates a shortened QT interval.

Arrange the following management steps in the most appropriate temporal sequence for the acute stabilization and definitive therapy of this patient, from initial action to long-term management.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequential order is: 1) Initiate aggressive intravenous volume expansion with 0.9% normal saline, 2) Administer calcitonin, 3) Administer an intravenous bisphosphonate, 4) Direct systemic therapy against the underlying relapsed malignancy.
The proper sequence for managing severe symptomatic hypercalcemia (> 14 mg/dL) begins with aggressive intravenous hydration (isotonic saline) to reverse severe volume depletion and improve renal calcium excretion. Because hydration alone is insufficient, calcitonin is administered to rapidly lower calcium levels within hours. Intravenous bisphosphonates (like zoledronic acid) are given to provide a sustained reduction in serum calcium, but because they take 48-72 hours to achieve full effect and can be nephrotoxic in dehydrated patients, they are administered following initial volume expansion. Finally, treating the underlying malignancy provides definitive, long-term resolution of the condition.

Adım Adım Çözüm

1
Assess the clinical presentation and laboratory data.
The patient has severe symptomatic hypercalcemia (calcium > 14 mg/dL) complicated by profound dehydration and acute kidney injury.
Identifying the severity of hypercalcemia and its physiological impact on volume status dictates the urgency and sequence of interventions.
2
Select the most critical initial stabilization measure.
Intravenous volume expansion with isotonic saline is chosen as the first step.
Hypercalcemia causes a nephrogenic diabetes insipidus-like state, leading to severe volume depletion. Restoring intravascular volume improves glomerular filtration and increases renal calcium clearance.
3
Select the rapid-acting pharmacological therapy.
Calcitonin is administered next.
Calcitonin acts rapidly (within hours) to inhibit osteoclast function, bridging the temporal gap before long-acting agents take full effect.
4
Select the long-acting pharmacological therapy.
An intravenous bisphosphonate is administered.
Bisphosphonates provide sustained calcium reduction but take 48-72 hours to reach maximum effect. They must follow initial hydration to reduce the risk of nephrotoxicity.
5
Determine the definitive long-term management.
Systemic therapy for the underlying malignancy is planned.
Treating the root cause (relapsed breast cancer) is essential to prevent recurrent hypercalcemia once the acute crisis is managed.

Anahtar Kavram

The acute management of severe symptomatic hypercalcemia requires sequential, targeted interventions: initial aggressive volume expansion, followed by rapid-acting agents (calcitonin), long-acting agents (bisphosphonates), and ultimately treating the underlying malignant cause.
Tahmini Süre:1m 30s
Soru 2236Soru →

A 19-year-old college student is admitted to the hospital with a two-day history of fever, severe headache, photophobia, and neck stiffness. On physical examination, the patient is alert but uncomfortable. Temperature is 38.6°C (101.5°F), blood pressure is 118/76 mm Hg, and pulse is 98/min. Nuchal rigidity is present. A lumbar puncture is performed, and empiric intravenous ceftriaxone and vancomycin are initiated. Cerebrospinal fluid (CSF) analysis reveals a leukocyte count of 140/mm³ with 92% lymphocytes, a glucose level of 65 mg/dL (serum glucose 90 mg/dL), and a protein level of 40 mg/dL. Gram stain reveals no organisms. A multiplex polymerase chain reaction (PCR) assay of the CSF is positive for enterovirus and negative for all common bacterial pathogens. Which of the following is the most appropriate next step in this patient's pharmacologic management?

Cevabı ve açıklamayı göster

Cevap: Discontinue all antibacterial therapy

Cevap

Discontinue all antibacterial therapy
The patient's clinical presentation and cerebrospinal fluid (CSF) findings (lymphocytic pleocytosis, normal glucose, normal protein) are classic for aseptic meningitis. The definitive diagnosis is established by the multiplex PCR assay, which is highly sensitive and specific, returning positive for enterovirus and negative for bacterial targets. Enteroviruses are the most common cause of viral meningitis. Because the etiology is confirmed to be viral, there is no role for antibacterial therapy. The most appropriate next step is to discontinue the empiric ceftriaxone and vancomycin to adhere to principles of antibiotic stewardship, minimizing the risk of adverse drug reactions, Clostridioides difficile infection, and the development of antimicrobial resistance. Management of enteroviral meningitis is strictly supportive.

Adım Adım Çözüm

1
Analyze the cerebrospinal fluid (CSF) cell count and differential.
The CSF shows a mild pleocytosis (140/mm³) with a strong lymphocyte predominance (92%), alongside normal glucose and normal protein levels.
This pattern is highly characteristic of aseptic (viral) meningitis, distinguishing it from the profound neutrophilic pleocytosis and hypoglycorrhachia typically seen in bacterial meningitis.
2
Interpret the CSF multiplex PCR assay results.
The assay is positive for enterovirus and negative for all common bacterial pathogens.
Multiplex PCR is highly sensitive and specific. A positive result for enterovirus definitively identifies the causative pathogen for the patient's aseptic meningitis.
3
Determine the appropriate pharmacologic intervention based on the definitive diagnosis.
Discontinue the empiric antibacterial agents (ceftriaxone and vancomycin).
Because the infection is definitively viral, antibiotics provide no therapeutic benefit. Their continuation violates antibiotic stewardship principles, increasing the risk of adverse drug events and antimicrobial resistance.

Anahtar Kavram

In patients with suspected meningitis who are empirically started on antibiotics, a definitive diagnosis of viral meningitis via CSF PCR (e.g., enterovirus) should prompt the immediate discontinuation of antibacterial therapy.
Tahmini Süre:1m 0s
Soru 2237Soru →

A 34-year-old woman is brought to the emergency department by her husband due to progressive confusion and severe fatigue over the past 48 hours. Her temperature is 37.8∘C37.8^\circ\text{C}, blood pressure is 142/88 mmHg142/88 \text{ mmHg}, and pulse is 108/min108/\text{min}. Physical examination reveals scleral icterus and scattered petechiae on the lower extremities. Neurological examination shows mild disorientation but no focal motor deficits.

Laboratory studies show:

Laboratory TestResultReference Range
Hemoglobin7.4 g/dL7.4 \text{ g/dL}12.0−16.0 g/dL12.0-16.0 \text{ g/dL}
Platelet count18,000/mm318,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Mean corpuscular volume86 fL86 \text{ fL}80−100 fL80-100 \text{ fL}
Creatinine1.6 mg/dL1.6 \text{ mg/dL}0.6−1.2 mg/dL0.6-1.2 \text{ mg/dL}
Total bilirubin3.8 mg/dL3.8 \text{ mg/dL}0.1−1.2 mg/dL0.1-1.2 \text{ mg/dL}
Direct bilirubin0.6 mg/dL0.6 \text{ mg/dL}0.0−0.3 mg/dL0.0-0.3 \text{ mg/dL}
Lactate dehydrogenase (LDH)1,450 U/L1,450 \text{ U/L}100−250 U/L100-250 \text{ U/L}
INR1.11.10.8−1.20.8-1.2
aPTT32 seconds32 \text{ seconds}25−40 seconds25-40 \text{ seconds}

Arrange the following clinical steps in the most appropriate sequential order for the evidence-based diagnosis and management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Review a peripheral blood smear -> Calculate the PLASMIC score -> Obtain a venous blood sample for ADAMTS13 -> Initiate emergent therapeutic plasma exchange (PLEX) -> Administer high-dose systemic glucocorticoids.
The patient's presentation of MAHA, severe thrombocytopenia, mild renal impairment, and neurological symptoms without coagulopathy strongly suggests Thrombotic Thrombocytopenic Purpura (TTP). The evidence-based sequence begins with identifying MAHA on a peripheral smear. Next, a PLASMIC score is calculated to risk-stratify the patient; this patient has a high score due to hemolysis, platelets < 30,000, MCV < 90, normal INR, and Cr < 2.0. Critically, the blood sample for ADAMTS13 must be drawn *before* any plasma therapy is administered to prevent false-negative diagnostic results. Once the sample is secured, emergent therapeutic plasma exchange (PLEX) is initiated empirically without waiting for the ADAMTS13 results. Finally, adjunctive medical therapies like glucocorticoids are added to target the underlying autoimmune antibody production.

Adım Adım Çözüm

1
Evaluate the CBC and standard laboratory panels by reviewing a peripheral blood smear.
Confirmation of fragmented red blood cells (schistocytes), establishing the presence of microangiopathic hemolytic anemia (MAHA).
Before initiating invasive treatment for Thrombotic Thrombocytopenic Purpura (TTP), MAHA must be distinguished from other causes of pancytopenia or isolated thrombocytopenia.
2
Calculate the PLASMIC score using the patient's laboratory values and clinical history.
A high score (e.g., 6 or 7) strongly suggests severe ADAMTS13 deficiency.
This validated predictive tool helps clinicians justify the immediate use of high-risk, expensive empiric therapies (like PLEX) before definitive molecular testing results are available.
3
Draw a venous blood sample for an ADAMTS13 activity and inhibitor assay.
The diagnostic specimen is safely secured prior to any treatment.
PLEX utilizes donor fresh frozen plasma, which contains functional ADAMTS13 enzyme. Drawing blood after starting PLEX yields falsely normalized results, permanently obscuring the true diagnosis.
4
Initiate emergent therapeutic plasma exchange (PLEX).
Mechanical removal of ADAMTS13 autoantibodies and replenishment of the functional enzyme.
TTP is a medical emergency with high mortality if untreated. PLEX must be started immediately upon clinical suspicion and must not wait for the ADAMTS13 laboratory results.
5
Administer systemic immunosuppressants, such as high-dose glucocorticoids.
Suppression of the underlying autoimmune pathophysiology.
While PLEX manages the acute thrombotic crisis, immunosuppressants halt the ongoing production of the pathogenic IgG autoantibodies.

Anahtar Kavram

Diagnosis and stepwise management algorithm for Thrombotic Thrombocytopenic Purpura (TTP)
Soru 2238Soru →

Following a deceased-donor renal allograft transplantation eight months ago, a 58-year-old woman is admitted to the hospital due to a three-week history of productive cough, night sweats, and new-onset left-sided hemiparesis. Her immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. Routine post-transplant antimicrobial prophylaxis was discontinued two months ago. Vital signs show a temperature of 38.2°C (100.8°F). Neurological examination reveals 3/5 strength in the left upper and lower extremities. A chest radiograph demonstrates a large cavitary lesion in the right upper lobe. Subsequent magnetic resonance imaging of the brain reveals a 2.5-cm ring-enhancing lesion in the right frontal lobe with surrounding vasogenic edema. Bronchoscopy with bronchoalveolar lavage is performed, and cytological analysis reveals branching, filamentous, Gram-positive rods that stain weakly positive with a modified acid-fast stain. Which of the following is the most appropriate initial targeted pharmacotherapy for this patient's underlying infection?

Cevabı ve açıklamayı göster

Cevap: Trimethoprim-sulfamethoxazole

Cevap

Trimethoprim-sulfamethoxazole
The correct answer is trimethoprim-sulfamethoxazole. This immunocompromised patient's presentation of a cavitary lung lesion and a ring-enhancing brain abscess is highly characteristic of disseminated nocardiosis. The diagnosis is definitively supported by the bronchoalveolar lavage findings: branching, filamentous, Gram-positive rods that are weakly positive on modified acid-fast staining. Nocardia species are aerobic, soil-dwelling bacteria that cause opportunistic pulmonary infections with a strong propensity for hematogenous dissemination to the central nervous system. Trimethoprim-sulfamethoxazole (TMP-SMX) is the cornerstone of targeted therapy for nocardiosis. In severe or disseminated cases, a second agent like a carbapenem (e.g., imipenem) or amikacin may be added empirically, but TMP-SMX remains the essential targeted agent.

Adım Adım Çözüm

1
Analyze the patient's immune status and clinical presentation.
The patient is an immunocompromised solid organ transplant recipient presenting with a dual-organ syndrome: a cavitary pulmonary infection and a focal central nervous system (CNS) abscess.
Identifying the pattern of organ involvement narrows the differential diagnosis of opportunistic infections to pathogens that typically disseminate from the lungs to the brain (e.g., Nocardia, Aspergillus, Tuberculosis).
2
Interpret the specific microbiological findings from the bronchoalveolar lavage.
The pathogen is described as branching, filamentous, Gram-positive rods that are weakly acid-fast.
These specific staining characteristics are pathognomonic for Nocardia species. They differentiate the organism from Actinomyces (which is not acid-fast) and Aspergillus (which is a fungus, not a Gram-positive bacterium).
3
Determine the appropriate targeted pharmacotherapy for the identified pathogen.
Trimethoprim-sulfamethoxazole is selected as the cornerstone of therapy.
Trimethoprim-sulfamethoxazole is the standard first-line targeted therapy for both pulmonary and disseminated (CNS) nocardiosis.

Anahtar Kavram

Nocardiosis presents as cavitary lung lesions and brain abscesses in immunocompromised patients, diagnosed by weakly acid-fast, branching Gram-positive rods, and is treated with trimethoprim-sulfamethoxazole.
Tahmini Süre:1m 30s
Soru 2239Soru →

Match each clinical presentation of a chemotherapy-induced adverse effect to the specific antineoplastic agent responsible for the toxicity.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 28-year-old man receiving bleomycin, etoposide, and cisplatin for testicular cancer develops a dry cough and progressive dyspnea; pulmonary function tests show a restrictive pattern.
A 48-year-old woman receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone for non-Hodgkin lymphoma presents with suprapubic pain and gross hematuria.
A 62-year-old man receiving bleomycin, etoposide, and cisplatin for advanced testicular cancer complains of persistent bilateral tinnitus and progressive sensorineural hearing loss.
A 55-year-old woman receiving doxorubicin and cyclophosphamide for breast cancer develops new-onset orthopnea, bilateral basilar crackles, and a reduced left ventricular ejection fraction.
A 60-year-old man receiving rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone for diffuse large B-cell lymphoma reports a subacute 'pins and needles' sensation in his distal extremities and absent ankle reflexes.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align the clinical toxicity to its specific causative agent: Bleomycin causes pulmonary fibrosis; Cyclophosphamide causes hemorrhagic cystitis; Cisplatin causes ototoxicity; Doxorubicin causes dilated cardiomyopathy; and Vincristine causes peripheral neuropathy.
Each clinical scenario describes a classic dose-limiting toxicity that corresponds to exactly one agent in the patient's regimen. Bleomycin causes pulmonary fibrosis; Cyclophosphamide causes hemorrhagic cystitis; Cisplatin causes ototoxicity; Doxorubicin causes dilated cardiomyopathy; and Vincristine causes peripheral neuropathy.

Adım Adım Çözüm

1
Analyze the first vignette describing restrictive lung disease in a patient on BEP therapy.
The primary symptom is pulmonary fibrosis.
Identifying the specific organ toxicity allows isolation of the responsible drug from the combination regimen.
2
Match pulmonary fibrosis to its causative agent in the BEP regimen.
Bleomycin is the correct match.
Bleomycin is classically associated with dose-dependent pulmonary toxicity.
3
Analyze the second vignette describing gross hematuria in a patient on R-CHOP therapy.
The presentation represents hemorrhagic cystitis.
This is a classic urologic emergency associated with specific alkylating agents.
4
Match hemorrhagic cystitis to its causative agent.
Cyclophosphamide is the correct match.
Acrolein, a cyclophosphamide metabolite, is highly toxic to the bladder epithelium.
5
Analyze the third vignette describing tinnitus and hearing loss in a patient on BEP therapy.
The symptom is ototoxicity.
Hearing loss is a highly specific neurological toxicity that must be recognized.
6
Match ototoxicity to its causative agent.
Cisplatin is the correct match.
Platinum analogues, especially cisplatin, are heavily ototoxic and nephrotoxic.
7
Analyze the fourth vignette describing heart failure (reduced ejection fraction) in a patient on AC therapy.
The symptom is dilated cardiomyopathy.
Cardiotoxicity is a dose-limiting side effect for certain key oncology drugs.
8
Match dilated cardiomyopathy to its causative agent.
Doxorubicin is the correct match.
Anthracyclines like doxorubicin cause cumulative myocardial free-radical damage.
9
Analyze the fifth vignette describing absent ankle reflexes and paresthesias in a patient on R-CHOP therapy.
The symptom is peripheral neuropathy.
Areflexia and a 'pins and needles' sensation indicate peripheral nerve damage.
10
Match peripheral neuropathy to its causative agent.
Vincristine is the correct match.
Vinca alkaloids disrupt microtubules, uniquely causing peripheral neuropathy rather than the severe myelosuppression seen with other agents.

Anahtar Kavram

Major chemotherapeutic agents have distinct, highly tested dose-limiting toxicities that must be recognized when patients on combination regimens present with new symptoms.
Soru 2240Soru →

Match each patient's clinical presentation with the autoantibody or immunologic marker most strongly associated with their underlying disease process.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 48-year-old woman presenting with proximal muscle weakness, hyperkeratotic cracking on the lateral aspects of her fingers, and new-onset interstitial lung disease.
A 32-year-old woman with a history of unprovoked pulmonary embolism presenting with recurrent mid-trimester pregnancy losses and an isolated prolonged PTT.
A 55-year-old man with palpable purpura, arthralgias, peripheral neuropathy, and hypocomplementemia (low C4), who recently tested positive for Hepatitis C.
A 60-year-old woman with severe xerophthalmia, xerostomia, and bilateral parotid gland enlargement who recently noticed a rapidly enlarging cervical lymph node.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Antisynthetase syndrome matches with Anti-Jo-1; Antiphospholipid syndrome matches with Anti-beta-2-glycoprotein I; Mixed cryoglobulinemia matches with Rheumatoid factor; Sjögren syndrome matches with Anti-Ro/SSA.
Each left item provides a high-yield, specific clinical vignette for a systemic autoimmune disease. Antisynthetase syndrome is driven by anti-Jo-1; antiphospholipid syndrome relies on markers like anti-beta-2-glycoprotein I; Hepatitis C-associated mixed cryoglobulinemia features IgM rheumatoid factor; and Sjögren syndrome is characterized by anti-Ro/SSA antibodies.

Adım Adım Çözüm

1
Analyze the first patient's symptoms (myositis, mechanic's hands, interstitial lung disease) to diagnose antisynthetase syndrome.
Identify Anti-Jo-1 as the highly specific antibody for this condition.
Anti-Jo-1 targets histidyl-tRNA synthetase and defines this distinct subset of inflammatory myopathies.
2
Evaluate the second patient's history of thrombosis, pregnancy loss, and isolated prolonged PTT to diagnose antiphospholipid syndrome.
Identify Anti-beta-2-glycoprotein I as one of the defining diagnostic autoantibodies.
The prolonged PTT is an in vitro artifact of the lupus anticoagulant; the syndrome is mediated by antibodies against phospholipid-binding proteins.
3
Correlate the third patient's palpable purpura, neuropathy, low C4, and Hepatitis C with mixed cryoglobulinemia.
Identify Rheumatoid factor as the key immunologic marker.
Type II mixed cryoglobulins are immune complexes composed of polyclonal IgG and monoclonal IgM; the IgM component possesses rheumatoid factor activity (affinity for the Fc portion of IgG), which consumes complement C4.
4
Recognize the fourth patient's sicca symptoms, parotid swelling, and new lymphadenopathy as Sjögren syndrome with likely lymphomatous transformation.
Identify Anti-Ro/SSA antibodies as the classic serologic marker.
Sjögren syndrome carries a significantly elevated risk for B-cell non-Hodgkin lymphoma, and is diagnosed using Anti-Ro/SSA and Anti-La/SSB antibodies.

Anahtar Kavram

Clinical and serologic correlations in systemic autoimmune and rheumatic diseases
ÖncekiSayfa 112 / 414Sonraki